Products for Research Use Only
RegisterLogin

Lucerastat

CAT: 0013-GTR19193670Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19193670Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lucerastat (NBDGJ) is an orally administered glucosylceramide synthase (GCS) inhibitor investigated for Fabry disease. By blocking a key step in sphingolipid biosynthesis, it reduces the accumulation of pathogenic substrates, as demonstrated in relevant cellular and animal models of lysosomal storage disorders.
CAS Number
141206-42-0
Field of Research
Metabolism Research
Purity
98.00% (May vary between batches)
Smiles
C (CCC) N1[C@H] (CO) [C@H] (O) [C@H] (O) [C@@H] (O) C1
Molecular Formula
C10H21NO4
Molecular Weight
219.28
Storage Conditions
-20°C
Notes
For research use only.

Alternative Products

CatalogName
HY-106392-01Lucerastat
HY-106392R-01Lucerastat (Standard)
AR-M04672-01Migalastat Impurity 1 (Lucerastat)

Popular Products